- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical targeting of the TNF and TNFR superfamilies
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 12, Issue 2, Pages 147-168
Publisher
Springer Nature
Online
2013-01-21
DOI
10.1038/nrd3930
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase I study of CS-1008 (humanized monoclonal antibody targeting death receptor 5 or DR5), administered weekly to patients with advanced solid tumors or lymphomas
- (2017) M. N. Saleh et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I trial of LBY135, a monoclonal antibody agonist to DR5, alone and in combination with capecitabine in advanced solid tumors
- (2017) S. Sharma et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I study of BMS-663513, a fully human anti-CD137 agonist monoclonal antibody, in patients (pts) with advanced cancer (CA)
- (2017) M. Sznol et al. JOURNAL OF CLINICAL ONCOLOGY
- Cutting Edge: The Dependence of Plasma Cells and Independence of Memory B Cells on BAFF and APRIL
- (2014) M. J. Benson et al. JOURNAL OF IMMUNOLOGY
- Glucocorticoid-Induced Tumor Necrosis Factor Receptor Family-Related Protein Exacerbates Collagen-Induced Arthritis by Enhancing the Expansion of Th17 Cells
- (2012) Shengjun Wang et al. AMERICAN JOURNAL OF PATHOLOGY
- Long-Term Hepatic Allograft Acceptance Based on CD40 Blockade by ASKP1240 in Nonhuman Primates
- (2012) T. Oura et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer
- (2012) H. L. Kindler et al. ANNALS OF ONCOLOGY
- The anti-Fn14 antibody BIIB036 inhibits tumor growth in xenografts and patient derived primary tumor models and enhances efficacy of chemotherapeutic agents in multiple xenograft models
- (2012) Jennifer S. Michaelson et al. CANCER BIOLOGY & THERAPY
- Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activity
- (2012) Timothy S. Fisher et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Development of a Human Monoclonal Antibody for Potential Therapy of CD27-Expressing Lymphoma and Leukemia
- (2012) L. A. Vitale et al. CLINICAL CANCER RESEARCH
- Phase I Study of Atacicept in Relapsed/Refractory Multiple Myeloma (MM) and Waldenström's Macroglobulinemia
- (2012) Jean-François Rossi Clinical Lymphoma Myeloma & Leukemia
- First-line treatment of metastatic or locally advanced unresectable soft tissue sarcomas with conatumumab in combination with doxorubicin or doxorubicin alone: A Phase I/II open-label and double-blind study
- (2012) George D. Demetri et al. EUROPEAN JOURNAL OF CANCER
- Role of TWEAK in lupus nephritis: A bench-to-bedside review
- (2012) Jennifer S. Michaelson et al. JOURNAL OF AUTOIMMUNITY
- Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
- (2012) Anas Younes et al. JOURNAL OF CLINICAL ONCOLOGY
- The TWEAK/Fn14 pathway as an aggravating and perpetuating factor in inflammatory diseases; focus on inflammatory bowel diseases
- (2012) Taeko Dohi et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Tanezumab Reduces Osteoarthritic Knee Pain: Results of a Randomized, Double-Blind, Placebo-Controlled Phase III Trial
- (2012) Mark T. Brown et al. JOURNAL OF PAIN
- Phase I study of the anti-CD40 humanized monoclonal antibody lucatumumab (HCD122) in relapsed chronic lymphocytic leukemia
- (2012) John C. Byrd et al. LEUKEMIA & LYMPHOMA
- TRAIL Signaling and Synergy Mechanisms Used in TRAIL-Based Combination Therapies
- (2012) C. T. Hellwig et al. MOLECULAR CANCER THERAPEUTICS
- TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
- (2012) Adam P. Gregory et al. NATURE
- The discovery and development of belimumab: the anti-BLyS–lupus connection
- (2012) William Stohl et al. NATURE BIOTECHNOLOGY
- Anti-NGF painkillers back on track?
- (2012) David Holmes NATURE REVIEWS DRUG DISCOVERY
- Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab
- (2012) David L. Lacey et al. NATURE REVIEWS DRUG DISCOVERY
- In Vivo Depletion of Lymphotoxin-Alpha Expressing Lymphocytes Inhibits Xenogeneic Graft-versus-Host-Disease
- (2012) Eugene Y. Chiang et al. PLoS One
- Safety, pharmacokinetics, and biologic activity of pateclizumab, a novel monoclonal antibody targeting lymphotoxin α: results of a phase I randomized, placebo-controlled trial
- (2012) Brinda Emu et al. ARTHRITIS RESEARCH & THERAPY
- Serum OX40 ligand levels in asthmatic children: A potential biomarker of severity and persistence
- (2011) Mohamed Hesham Mohamed Ezzat et al. ALLERGY AND ASTHMA PROCEEDINGS
- CD40-Specific Costimulation Blockade Enhances Neonatal Porcine Islet Survival in Nonhuman Primates
- (2011) P. Thompson et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a phase II, randomized, placebo-controlled trial
- (2011) R. F. van Vollenhoven et al. ARTHRITIS AND RHEUMATISM
- Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: Results of a phase II, randomized, placebo-controlled, dose-finding trial
- (2011) M. C. Genovese et al. ARTHRITIS AND RHEUMATISM
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Dispensability of APRIL to the development of systemic lupus erythematosus in NZM 2328 mice
- (2011) Chaim O. Jacob et al. ARTHRITIS AND RHEUMATISM
- Decoy receptor 3: A pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer
- (2011) Wan-Wan Lin et al. BIOCHEMICAL PHARMACOLOGY
- Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas
- (2011) M. Guadagnoli et al. BLOOD
- Pharmacological modulation of GITRL/GITR system: therapeutic perspectives
- (2011) Giuseppe Nocentini et al. BRITISH JOURNAL OF PHARMACOLOGY
- Immune modulation with weekly dosing of an agonist CD40 antibody in a phase I study of patients with advanced solid tumors
- (2011) Jens Rüter et al. CANCER BIOLOGY & THERAPY
- An Fcγ Receptor-Dependent Mechanism Drives Antibody-Mediated Target-Receptor Signaling in Cancer Cells
- (2011) Nicholas S. Wilson et al. CANCER CELL
- Intravenous and intradermal TriMix-dendritic cell therapy results in a broad T-cell response and durable tumor response in a chemorefractory stage IV-M1c melanoma patient
- (2011) An M. T. Van Nuffel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Molecular Pathways: Osteoclast-Dependent and Osteoclast-Independent Roles of the RANKL/RANK/OPG Pathway in Tumorigenesis and Metastasis
- (2011) W. C. Dougall CLINICAL CANCER RESEARCH
- A Phase I Weekly Dosing Study of Brentuximab Vedotin in Patients with Relapsed/Refractory CD30-Positive Hematologic Malignancies
- (2011) M. A. Fanale et al. CLINICAL CANCER RESEARCH
- The TWEAK-Fn14 System: Breaking the Silence of Cytokine-Induced Skeletal Muscle Wasting
- (2011) S. Bhatnagar et al. CURRENT MOLECULAR MEDICINE
- TNF Superfamily Networks: bidirectional and interference pathways of the herpesvirus entry mediator (TNFSF14)
- (2011) Carl F Ware et al. CURRENT OPINION IN IMMUNOLOGY
- Enhancement of anti-tumor immunity through local modulation of CTLA-4 and GITR by dendritic cells
- (2011) Scott K. Pruitt et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Upregulation and nuclear localization of TNF-like Cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions
- (2011) Giorgos Bamias et al. EXPERIMENTAL DERMATOLOGY
- Conatumumab: a novel monoclonal antibody against death receptor 5 for the treatment of advanced malignancies in adults
- (2011) Madhuri Bajaj et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Blockade of cytotoxic T-lymphocyte antigen-4 as a new therapeutic approach for advanced melanoma
- (2011) Xiang-Yang Wang et al. EXPERT OPINION ON PHARMACOTHERAPY
- Interleukin-13 Damages Intestinal Mucosa via TWEAK and Fn14 in Mice—A Pathway Associated With Ulcerative Colitis
- (2011) Rei Kawashima et al. GASTROENTEROLOGY
- OX40 and CD30 signals in CD4+ T-cell effector and memory function: a distinct role for lymphoid tissue inducer cells in maintaining CD4+ T-cell memory but not effector function
- (2011) David R. Withers et al. IMMUNOLOGICAL REVIEWS
- TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses
- (2011) Linda C. Burkly et al. IMMUNOLOGICAL REVIEWS
- TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation
- (2011) Françoise Meylan et al. IMMUNOLOGICAL REVIEWS
- The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation
- (2011) Marcos W. Steinberg et al. IMMUNOLOGICAL REVIEWS
- T-cell intrinsic effects of GITR and 4-1BB during viral infection and cancer immunotherapy
- (2011) Laura M. Snell et al. IMMUNOLOGICAL REVIEWS
- The role of core TNF/LIGHT family members in lymph node homeostasis and remodeling
- (2011) Mingzhao Zhu et al. IMMUNOLOGICAL REVIEWS
- Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension
- (2011) Socrates Papapoulos et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non–Small-Cell Lung Cancer
- (2011) Jean-Charles Soria et al. JOURNAL OF CLINICAL ONCOLOGY
- B Cell Maturation Antigen Deficiency Exacerbates Lymphoproliferation and Autoimmunity in Murine Lupus
- (2011) C. Jiang et al. JOURNAL OF IMMUNOLOGY
- Accelerated central nervous system autoimmunity in BAFF-receptor-deficient mice
- (2011) Susan S. Kim et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Development of an Fn14 agonistic antibody as an anti-tumor agent
- (2011) Jennifer S. Michaelson et al. mAbs
- Targeting 4-1BB Costimulation to Disseminated Tumor Lesions With Bi-specific Oligonucleotide Aptamers
- (2011) Fernando Pastor et al. MOLECULAR THERAPY
- The tumor necrosis factor family member LIGHT is a target for asthmatic airway remodeling
- (2011) Taylor A Doherty et al. NATURE MEDICINE
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized, double-blind, dose-escalation, placebo-controlled study
- (2011) H. Nagashima et al. OSTEOARTHRITIS AND CARTILAGE
- Long-term open-label study of tanezumab for moderate to severe osteoarthritic knee pain
- (2011) T.J. Schnitzer et al. OSTEOARTHRITIS AND CARTILAGE
- Efficacy and safety of tanezumab in the treatment of chronic low back pain
- (2011) Nathaniel Katz et al. PAIN
- Blocking the effects of NGF as a route to safe and effective pain relief – fact or fancy?
- (2011) Ray Hill PAIN
- BAFF Promotes Th17 Cells and Aggravates Experimental Autoimmune Encephalomyelitis
- (2011) Xiaohui Zhou et al. PLoS One
- Therapeutic Targeting of CD95 and the TRAIL Death Receptors
- (2011) Jeannette Gerspach et al. Recent Patents on Anti-Cancer Drug Discovery
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
- The Involvement of Epithelial Fas in a Human Model of Graft Versus Host Disease
- (2011) Nicolas Ruffin et al. TRANSPLANTATION
- TNF superfamily in inflammatory disease: translating basic insights
- (2011) Michael Croft et al. TRENDS IN IMMUNOLOGY
- Serious pulmonary toxicity in patients with Hodgkin's lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an Fc RIIIa-158 V/F polymorphism
- (2010) K. A. Blum et al. ANNALS OF ONCOLOGY
- Control of Immunity by the TNFR-Related Molecule OX40 (CD134)
- (2010) Michael Croft Annual Review of Immunology
- A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma
- (2010) A Younes et al. BRITISH JOURNAL OF CANCER
- Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer
- (2010) T Trarbach et al. BRITISH JOURNAL OF CANCER
- Targeting pancreatic and ovarian carcinomas using the auristatin-based anti-CD70 antibody–drug conjugate SGN-75
- (2010) M C Ryan et al. BRITISH JOURNAL OF CANCER
- Treatment with anti-CD137 mAbs causes intense accumulations of liver T cells without selective antitumor immunotherapeutic effects in this organ
- (2010) Juan Dubrot et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Glucocorticoid-Induced TNFR-Related (GITR) Protein and Its Ligand in Antitumor Immunity: Functional Role and Therapeutic Modulation
- (2010) Theresa Placke et al. Clinical & Developmental Immunology
- A Phase I Safety and Pharmacokinetic Study of the Death Receptor 5 Agonistic Antibody PRO95780 in Patients with Advanced Malignancies
- (2010) D. R. Camidge et al. CLINICAL CANCER RESEARCH
- Antibodies to TWEAK Receptor Inhibit Human Tumor Growth through Dual Mechanisms
- (2010) P. A. Culp et al. CLINICAL CANCER RESEARCH
- Characteristics and Development of TRX518, an Aglycosyl Humanized Monoclonal Antibody (Mab) Agonist of huGITR
- (2010) Joe Ponte et al. CLINICAL IMMUNOLOGY
- TNFSF9 expression in primary biliary cirrhosis and its clinical significance
- (2010) Rong Xia et al. CYTOKINE
- A phase I multidose study of dacetuzumab (SGN-40; humanized anti-CD40 monoclonal antibody) in patients with multiple myeloma
- (2010) M. Hussein et al. HAEMATOLOGICA
- Development, validation and application of ELISAs for pharmacokinetic and HACA assessment of a chimeric anti-CD40 monoclonal antibody in human serum
- (2010) F. Chowdhury et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Polymorphic Variants of LIGHT (TNF Superfamily-14) Alter Receptor Avidity and Bioavailability
- (2010) T. C. Cheung et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Novel Function of B Cell-Activating Factor in the Induction of IL-10-Producing Regulatory B Cells
- (2010) M. Yang et al. JOURNAL OF IMMUNOLOGY
- CD137-Mediated Pathogenesis from Chronic Hepatitis to Hepatocellular Carcinoma in Hepatitis B Virus-Transgenic Mice
- (2010) J. Wang et al. JOURNAL OF IMMUNOLOGY
- Tumor Necrosis Factor Receptor/Tumor Necrosis Factor Family Members in Antiviral CD8 T-Cell Immunity
- (2010) Shahram Salek-Ardakani et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- A phase I study of dacetuzumab (SGN-40, a humanized anti-CD40 monoclonal antibody) in patients with chronic lymphocytic leukemia
- (2010) Richard R. Furman et al. LEUKEMIA & LYMPHOMA
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
- (2010) Richard A Morgan et al. MOLECULAR THERAPY
- B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
- (2010) Massimo Ammirante et al. NATURE
- Tumor necrosis factor blockade and the risk of viral infection
- (2010) Seo Young Kim et al. Nature Reviews Rheumatology
- APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivo
- (2010) G. Eisele et al. NEURO-ONCOLOGY
- Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee
- (2010) Nancy E. Lane et al. NEW ENGLAND JOURNAL OF MEDICINE
- Denosumab prevents metacarpal shaft cortical bone loss in patients with erosive rheumatoid arthritis
- (2010) John T. Sharp et al. ARTHRITIS CARE & RESEARCH
- Denosumab-mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients
- (2010) A. Deodhar et al. ARTHRITIS CARE & RESEARCH
- Atacicept: targeting B cells in multiple sclerosis
- (2010) Hans-Peter Hartung et al. Therapeutic Advances in Neurological Disorders
- A Human Anti-CD40 Monoclonal Antibody, 4D11, for Kidney Transplantation in Cynomolgus Monkeys: Induction and Maintenance Therapy
- (2009) T. Aoyagi et al. AMERICAN JOURNAL OF TRANSPLANTATION
- T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model
- (2009) A. Di Stasi et al. BLOOD
- Atacicept in relapsed/refractory multiple myeloma or active Waldenström's macroglobulinemia: a phase I study
- (2009) J-F Rossi et al. BRITISH JOURNAL OF CANCER
- A Phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma
- (2009) Andres Forero-Torres et al. BRITISH JOURNAL OF HAEMATOLOGY
- A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma
- (2009) Johannes Haybaeck et al. CANCER CELL
- TNF superfamily: Costimulation and clinical applications
- (2009) Dass S. Vinay et al. CELL BIOLOGY INTERNATIONAL
- Combining Radiotherapy with APO010 in Cancer Treatment
- (2009) I. Verbrugge et al. CLINICAL CANCER RESEARCH
- A Phase II Study of SGN-30 in Cutaneous Anaplastic Large Cell Lymphoma and Related Lymphoproliferative Disorders
- (2009) M. Duvic et al. CLINICAL CANCER RESEARCH
- Origins and functional basis of regulatory CD11c+CD8+T cells
- (2009) Dass S. Vinay et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-1 and receptor-2 agonists for cancer therapy
- (2009) Norma Lynn Fox et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- The strength of the Fas ligand signal determines whether hepatocytes act as type 1 or type 2 cells in murine livers
- (2009) Sven Schüngel et al. HEPATOLOGY
- The Many Roles of FAS Receptor Signaling in the Immune System
- (2009) Andreas Strasser et al. IMMUNITY
- Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology
- (2009) Martijn A. Nolte et al. IMMUNOLOGICAL REVIEWS
- Targeted depletion of lymphotoxin-α–expressing TH1 and TH17 cells inhibits autoimmune disease
- (2009) Eugene Y Chiang et al. NATURE MEDICINE
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
- (2009) Daniel E. Furst SEMINARS IN ARTHRITIS AND RHEUMATISM
- CD40 and autoimmunity: The dark side of a great activator
- (2009) Anna L. Peters et al. SEMINARS IN IMMUNOLOGY
- A novel form of 4-1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicity
- (2009) Rich-Henry Schabowsky et al. VACCINE
- OX40 (CD134) expression in sentinel lymph nodes correlates with prognostic features of primary melanomas
- (2008) MaryClare Sarff et al. AMERICAN JOURNAL OF SURGERY
- The effect of anti-CD40 ligand in immune thrombocytopenic purpura
- (2008) Vivek L. Patel et al. BRITISH JOURNAL OF HAEMATOLOGY
- The BLyS Family: Toward a Molecular Understanding of B Cell Homeostasis
- (2008) John F. Treml et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- CD137 Is Expressed in Human Atherosclerosis and Promotes Development of Plaque Inflammation in Hypercholesterolemic Mice
- (2008) Peder S. Olofsson et al. CIRCULATION
- Phase I Clinical Study of Atacicept in Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma
- (2008) S. M. Ansell et al. CLINICAL CANCER RESEARCH
- Preclinical Characterization of SGN-70, a Humanized Antibody Directed against CD70
- (2008) J. A. McEarchern et al. CLINICAL CANCER RESEARCH
- Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis
- (2008) Giorgos Bamias et al. CLINICAL IMMUNOLOGY
- Targeting tumors with LIGHT to generate metastasis-clearing immunity
- (2008) Ping Yu et al. CYTOKINE & GROWTH FACTOR REVIEWS
- APRIL (TNFSF13) regulates collagen-induced arthritis, IL-17 production and Th2 response
- (2008) Yanping Xiao et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Comparative Analysis of the Expression Patterns of Various TNFSF/TNFRSF in Atherosclerotic Plaques
- (2008) Won-Jung Kim et al. IMMUNOLOGICAL INVESTIGATIONS
- Inhibition of the lymphotoxin pathway as a therapy for autoimmune disease
- (2008) Jeffrey L. Browning IMMUNOLOGICAL REVIEWS
- Ligand-Based Targeting of Apoptosis in Cancer: The Potential of Recombinant Human Apoptosis Ligand 2/Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (rhApo2L/TRAIL)
- (2008) Avi Ashkenazi et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacokinetics and Biological Activity of Atacicept in Patients With Rheumatoid Arthritis
- (2008) Ivan Nestorov et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Clinical association of serum CD137 (4-1BB) levels in patients with systemic sclerosis
- (2008) Yasuhito Hamaguchi et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- The TWEAK–Fn14 cytokine–receptor axis: discovery, biology and therapeutic targeting
- (2008) Jeffrey A. Winkles NATURE REVIEWS DRUG DISCOVERY
- Reverse signaling initiated from GITRL induces NF-κB activation through ERK in the inflammatory activation of macrophages
- (2007) Eun Mi Bae et al. MOLECULAR IMMUNOLOGY
- Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
- (2007) Daniel Tracey et al. PHARMACOLOGY & THERAPEUTICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started